Bronchoalveolar lavage fluid cells in mixed connective tissue disease

Respirology

Volumn 8, Issue 2, 2003, Pages 149-156

  Enomoto, Katsumi ^a   Takada, Toshinori ^a   Suzuki, Eiichi ^a   Ishida, Takashi ^a   Moriyama, Hiroshi ^a   Ooi, Hidemi ^a   Hasegawa, Takashi ^a   Tsukada, Hiroki ^a   Nakano, Masaaki ^a   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Alveolar macrophages; Bronchoalveolar lavage; Interstitial lung diseases; Mixed connective tissue disease; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD71 ANTIGEN; CD8 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; LUNG LAVAGE; LYMPHOCYTE; MALE; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CD4-CD8 RATIO; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; IMMUNOPHENOTYPING; LUNG DISEASES, INTERSTITIAL; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; T-LYMPHOCYTE SUBSETS;

EID: 10744227018     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2003.00445.x     Document Type: Article

References (43)

1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am. J. Med. 1972; 52: 148-59.
2. Lazaro MA, Maldonado Cocco JA, Catoggio LJ, Babini SM, Messina OD, Garcia Morteo O. Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity? Medicine (Baltimore) 1989; 68: 58-65.
3. O'Connell DJ, Bennett RM. Mixed connective tissue disease: clinical and radiological aspects of 20 cases. Br. J. Radiol. 1977; 50: 620-5.
4. Wiener-Kronish JP, Solinger AM, Warnock ML, Churg A, Ordonez N, Golden JA. Severe pulmonary involvement in mixed connective tissue disease. Am. Rev. Respir. Dis. 1981; 124: 499-503.
5. Derderian SS, Tellis CJ, Abbrecht PH, Welton RC, Rajagopal KR. Pulmonary involvement in mixed connective tissue disease. Chest 1985; 88: 45-8.
6. Prakash UB, Luthra HS, Divertie MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin. Proc. 1985; 60: 813-21.
7. Prakash UB. Pulmonary manifestations in mixed connective tissue disease. Seminars Respiratory Med. 1988; 9: 318-24.
8. Vitali C, Tavoni A, Viegi G, Begliomini E, Agnesi A, Bombardieri S. Lung involvement in Sjogren's syndrome: a comparison between patients with primary and with secondary syndrome. Ann. Rheum. Dis. 1985; 44: 455-61.
9. Saito Y, Terada M, Takada T et al. Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. J. Comput. Assist. Tomogr. 2002; 26: 349-57.
10. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum. 1995; 38: 551-8.
11. The BAL Cooperative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am. Rev. Respir. Dis. 1990; 141: S169-202.
12. Gudbjornsson B, Hallgren R, Nettelbladt O et al. Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome. Ann. Rheum. Dis. 1994; 53: 574-9.
13. Wallaert B, Bart F, Aerts C et al. Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases. Thorax 1988; 43: 24-30.
14. Silver RM, Miller KS, Kinsella MB, Smith EA, Schabel SI. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am. J. Med. 1990; 88: 470-6.
15. Kourakata H, Takada T, Suzuki E et al. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia. Respirology 1999; 4: 223-8.
16. Nagai N. The value of BALF cell findings for differentiation of idiopathic UIP, BOOP, and interstitial pneumonia associated with collagen vascular disease. In: Harasawa M, Fukuchi Y, Morinari H (eds). Interstitial Pneumonia of Unknown Etiology. University of Tokyo Press, Tokyo, 1989; 27.
17. Kasukawa R, Tojo T, Miyawaki S et al. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp G (eds). Mixed Connective Tissue Disease and Anti-Nuclear Antibodies: Proceedings of the International Symposium on Mixed Connective Tissue Disease and Anti-Nuclear Antibodies, Tokyo, 29-30 August 1986, International Congress Series, Amsterdam, 1987; 41-7.
18. Vitali C, Bombardieri S, Moutsopoulos HM et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993; 36: 340-7.
19. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980; 23: 581-90.
20. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 1975; 292: 344-7.
21. Sharp G. Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp G (eds). Mixed Connective Tissue Disease and Anti-Nuclear Antibodies: Proceedings of the International Symposium on Mixed Connective Tissue Disease and Anti-Nuclear Antibodies, Tokyo, 29-30 August 1986, International Congress Series, Amsterdam, 1987; 23-32.
22. Kahn M, Appelboom T. Syndrom de Sharp. In: Kahn M, Peltier A, Meyer O, Piette J (eds). Les maladies systemiques. Flammarion, Paris, 1991; 545.
23. Alarcon-Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp G (eds). Mixed Connective Tissue Disease and Anti-Nuclear Antibodies: Proceedings of the International Symposium on Mixed Connective Tissue Disease and Anti-Nuclear Antibodies, Tokyo, 29-30 August 1986, International Congress Series, Amsterdam, 1987; 33-40.
24. Lukacher AE, Morrison LA, Braciale VL, Braciale TJ. T lymphocyte function in recovery from experimental viral infection: the influenza model. In: Steinman RM (ed.). Mechanisms of Host Resistance to Infectious Agents, Tumors, and Allografts. The Rockefeller University Press, New York, 1986; 233-54.
25. Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases. Am. Rev. Respir. Dis. 1979; 119: 471-503.
26. Salmeron G, Greenberg SD, Lidsky MD. Polymyositis and diffuse interstitial lung disease. A review of the pulmonary histopathologic findings. Arch. Intern. Med. 1981; 141: 1005-10.
27. Duncan PE, Griffin JP, Garcia A, Kaplan SB. Fibrosing alveolitis in polymyositis. A review of histologically confirmed cases. Am. J. Med. 1974; 57: 621-6.
28. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am. Rev. Respir. Dis. 1990; 141: 727-33.
29. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann. Intern. Med. 1995; 122: 715-24.
30. Skold CM, Eklund A, Hallden G, Hed J. Different cell surface and phagocytic properties in mononuclear phagocytes from blood and alveoli. A comparative study of blood monocytes and alveolar macrophages from human nonsmokers using flow cytofluorometry. Apmis 1990; 98: 415-22.
31. Zwadlo G, Brocker EB, von Bassewitz DB, Feige U, Sorg C. A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J. Immunol. 1985; 134: 1487-92.
32. Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989; 74: 2527-34.
33. Andreesen R, Brugger W, Scheibenbogen C et al. Surface phenotype analysis of human monocyte to macrophage maturation. J. Leukoc. Biol. 1990; 47: 490-7.
34. Viksman MY, Liu MC, Bickel CA, Schleimer RP, Bochner BS. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation. I. Evidence for activation of alveolar macrophages, but not peripheral blood monocytes, in subjects with allergic rhinitis and asthma. Am. J. Respir. Crit. Care Med. 1997; 155: 858-63.
35. Agostini C, Siviero M, Semenzato G. Immune effector cells in idiopathic pulmonary fibrosis. Curr. Opin. Pulm. Med. 1997; 3: 348-55.
36. Constantopoulos SH, Tsianos EV, Moutsopoulos HM. Pulmonary and gastrointestinal manifestations of Sjögren's syndrome. Rheum. Dis. Clin. North Am. 1992; 18: 617-35.
37. Bardana EJ Jr, Montanaro A. Sjögren's syndrome: a rheumatic disorder with prominent respiratory manifestations. Ann. Allergy 1990; 64: 3-10.
38. Moutsopoulos HM, Chused TM, Mann DL etal. Sjögren's syndrome (Sicca syndrome): current issues. Ann. Intern. Med. 1980; 92: 212-26.
39. Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sjögren's syndrome: a cross sectional and longitudinal study. Thorax 1991; 46: 180-3.
40. Cairns D, Shelley L, Burke WM et al. The differing patterns of interstitial lung involvement in connective tissue diseases. J. Rheumatol. 1992; 19: 1089-95.
41. Wallaert B, Prin L, Hatron PY, Ramon P, Tonnel AB, Voisin C. Lymphocyte subpopulations in bronchoalveolar lavage in Sjögren's syndrome. Evidence for an expansion of cytotoxic/suppressor subset in patients with alveolar neutrophilia. Chest 1987; 92: 1025-31.
42. Couturier C, Jahns G, Kazatchkine MD, Haeffner-Cavaillon N. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes. Eur. J. Immunol. 1992; 22: 1461-6.
43. Piguet PF, Ribaux C, Karpuz V, Grau GE, Kapanci Y. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am. J. Pathol. 1993; 143: 651-5.